ANTIROBE CAPSULE

Land: Canada

Språk: engelsk

Kilde: Health Canada

Aktiv ingrediens:

CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE)

Tilgjengelig fra:

ZOETIS CANADA INC

Dosering :

150MG

Legemiddelform:

CAPSULE

Sammensetning:

CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150MG

Administreringsrute:

ORAL

Enheter i pakken:

100

Resept typen:

Prescription

Terapeutisk gruppe:

DOGS

Produkt oppsummering:

Active ingredient group (AIG) number: 0105830002

Autorisasjon status:

APPROVED

Autorisasjon dato:

1997-05-08

Informasjon til brukeren

107 MM X 51 MM
DWG-101329-00
1613013
LABEL
13440
11731402
ANTIROBE
CANADA
TIME/DATE:
CHANGES
OK
CHANGES
OK
CHANGES
OK
EDITOR’S COPY
GS:
DATE:
PROJECT NO.
ARTWORK NUMBER
DESCRIPTION
COUNTRY
DIMENSIONS
DRAWING NO.
SKU NO.
ITEM
ADDITIONAL INFO:
COLORS:
Black
MGR
GS
GA
J. RUSTAD
W. FLOYD
C. FARRER
REV
_GA _
_PR _
_GS / ART REV (LCA) _
_GS / ART REV (FA)_
2
PMS 116
PMS 185
Dieline
LOT
EXP.
_CLINDAMYCIN _
_CAPSULES _
_(AS _
_CLINDAMYCIN HYDROCHLORIDE) / _
_CAPSULES _
_DE _
_CLINDAMYCINE (SOUS _
_FORME DE CHLORHYDRATE DE _
_CLINDAMYCINE)_
Veterinary Use Only Usage
vétérinaire seulement
ANTIBIOTIC / ANTIBIOTIQUE
for dogs / pour chiens
150 MG
_NET 100 CAPSULES_
MEDICINAL INGREDIENT: 150 mg of clindamycin (as clindamycin
hydrochloride)
per capsule.
INDICATIONS: For the treatment of infected wounds, abscesses and
dental infections
caused by or associated with _Staphylococcus _spp., _Streptococcus_
spp.,
_Bacteroides_ spp., _Fusobacterium necrophorum_ and _Clostridium
perfringens_ and
osteomyelitis caused by _Staphylococcus aureus_, in dogs.
DOSAGE AND ADMINISTRATION: _Infected Wounds, Abscesses and Dental
Infections_:
5.5 mg/kg body weight every 12 hours. _Osteomyelitis_: 11 mg/kg body
weight every
12 hours.
WARNINGS:_ _Keep out of reach of children. STORAGE: Store between 15
and 30°C.
SEE PACKAGE INSERT FOR COMPLETE DIRECTIONS FOR USE.
Zoetis is a trademark and Antirobe is a registered trademark of Zoetis
or its
licensors, used under license
by Zoetis Canada Inc.
Zoetis Canada Inc.
Kirkland QC H9H 4M7
INGRÉDIENT MÉDICINAL : 150 mg de clindamycine (sous forme de
chlorhydrate de
clindamycine) par capsule.
INDICATIONS : Pour le traitement des plaies infectées, des abcès ou
des
infections dentaires causées ou associées aux espèces
_Staphylococcus, _
_Streptococcus_, _Bacteroides_, à _Fusobacterium necrophorum_ ou
_Clostridium _
_perfringens_ et l’ostéomyélite causée par _Staphylococcus
aureus_ chez le chien.
POSOLOGIE ET ADMINISTRATION :
_Plaies infectées, abcès et infections dentaires_ : 5,5 mg/kg de
poids